A local human Vδ1 T cell population is associated with survival in nonsmall-cell lung cancer.


Journal

Nature cancer
ISSN: 2662-1347
Titre abrégé: Nat Cancer
Pays: England
ID NLM: 101761119

Informations de publication

Date de publication:
06 2022
Historique:
received: 26 10 2021
accepted: 11 04 2022
pubmed: 1 6 2022
medline: 30 6 2022
entrez: 31 5 2022
Statut: ppublish

Résumé

Murine tissues harbor signature γδ T cell compartments with profound yet differential impacts on carcinogenesis. Conversely, human tissue-resident γδ cells are less well defined. In the present study, we show that human lung tissues harbor a resident Vδ1 γδ T cell population. Moreover, we demonstrate that Vδ1 T cells with resident memory and effector memory phenotypes were enriched in lung tumors compared with nontumor lung tissues. Intratumoral Vδ1 T cells possessed stem-like features and were skewed toward cytolysis and helper T cell type 1 function, akin to intratumoral natural killer and CD8

Identifiants

pubmed: 35637401
doi: 10.1038/s43018-022-00376-z
pii: 10.1038/s43018-022-00376-z
pmc: PMC9236901
doi:

Substances chimiques

Receptors, Antigen, T-Cell, gamma-delta 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

696-709

Subventions

Organisme : Medical Research Council
ID : MR/V033077/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_17179
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 220589/Z/20/Z
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C11496/A30025
Pays : United Kingdom
Organisme : Cancer Research UK
ID : FC001169
Pays : United Kingdom
Organisme : Medical Research Council
ID : FC001169
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 203141/Z/16/Z
Pays : United Kingdom
Organisme : Department of Health
Pays : United Kingdom
Organisme : Wellcome Trust
ID : FC001169
Pays : United Kingdom
Organisme : Arthritis Research UK
ID : FC001169
Pays : United Kingdom

Investigateurs

Nicolai J Birkbak (NJ)
Gillian Price (G)
Mohammed Khalil (M)
Keith Kerr (K)
Shirley Richardson (S)
Heather Cheyne (H)
Tracey Cruickshank (T)
Gareth A Wilson (GA)
Rachel Rosenthal (R)
Hugo Aerts (H)
Madeleine Hewish (M)
Girija Anand (G)
Sajid Khan (S)
Kelvin Lau (K)
Michael Sheaff (M)
Peter Schmid (P)
Louise Lim (L)
John Conibear (J)
Roland Schwarz (R)
Tom L Kaufmann (TL)
Matthew Huska (M)
Jacqui Shaw (J)
Joan Riley (J)
Lindsay Primrose (L)
Dean Fennell (D)
Allan Hackshaw (A)
Yenting Ngai (Y)
Abigail Sharp (A)
Oliver Pressey (O)
Sean Smith (S)
Nicole Gower (N)
Harjot Kaur Dhanda (HK)
Kitty Chan (K)
Sonal Chakraborty (S)
Kevin Litchfield (K)
Krupa Thakkar (K)
Jonathan Tugwood (J)
Alexandra Clipson (A)
Caroline Dive (C)
Dominic Rothwell (D)
Alastair Kerr (A)
Elaine Kilgour (E)
Fiona Morgan (F)
Malgorzata Kornaszewska (M)
Richard Attanoos (R)
Helen Davies (H)
Katie Baker (K)
Mathew Carter (M)
Colin R Lindsay (CR)
Fabio Gomes (F)
Fiona Blackhall (F)
Lynsey Priest (L)
Matthew G Krebs (MG)
Anshuman Chaturvedi (A)
Pedro Oliveira (P)
Zoltan Szallasi (Z)
Gary Royle (G)
Catarina Veiga (C)
Marcin Skrzypski (M)
Roberto Salgado (R)
Miklos Diossy (M)
Alan Kirk (A)
Mo Asif (M)
John Butler (J)
Rocco Bilancia (R)
Nikos Kostoulas (N)
Mathew Thomas (M)
Mairead MacKenzie (M)
Maggie Wilcox (M)
Apostolos Nakas (A)
Sridhar Rathinam (S)
Rebecca Boyles (R)
Mohamad Tufail (M)
Amrita Bajaj (A)
Keng Ang (K)
Mohammed Fiyaz Chowdhry (MF)
Michael Shackcloth (M)
Julius Asante-Siaw (J)
Angela Leek (A)
Nicola Totten (N)
Jack Davies Hodgkinson (JD)
Peter Van Loo (P)
William Monteiro (W)
Hilary Marshal (H)
Kevin G Blyth (KG)
Craig Dick (C)
Charles Fekete (C)
Eric Lim (E)
Paulo De Sousa (P)
Simon Jordan (S)
Alexandra Rice (A)
Hilgardt Raubenheimer (H)
Harshil Bhayani (H)
Morag Hamilton (M)
Lyn Ambrose (L)
Anand Devaraj (A)
Hemangi Chavan (H)
Sofina Begum (S)
Silviu I Buderi (SI)
Daniel Kaniu (D)
Mpho Malima (M)
Sarah Booth (S)
Andrew G Nicholson (AG)
Nadia Fernandes (N)
Pratibha Shah (P)
Chiara Proli (C)
John Gosney (J)
Sarah Danson (S)
Jonathan Bury (J)
John Edwards (J)
Jennifer Hill (J)
Sue Matthews (S)
Yota Kitsanta (Y)
Jagan Rao (J)
Sara Tenconi (S)
Laura Socci (L)
Kim Suvarna (K)
Faith Kibutu (F)
Patricia Fisher (P)
Robin Young (R)
Joann Barker (J)
Fiona Taylor (F)
Kirsty Lloyd (K)
Jason Lester (J)
Mickael Escudero (M)
Aengus Stewart (A)
Andrew Rowan (A)
Jacki Goldman (J)
Richard Kevin Stone (RK)
Tamara Denner (T)
Emma Nye (E)
Maria Greco (M)
Jerome Nicod (J)
Clare Puttick (C)
Katey Enfield (K)
Emma Colliver (E)
Alastair Magness (A)
Chris Bailey (C)
Krijn Dijkstra (K)
Vittorio Barbè (V)
Roberto Vendramin (R)
Judit Kisistok (J)
Mateo Sokac (M)
Jonas Demeulemeester (J)
Elizabeth Larose Cadieux (EL)
Carla Castignani (C)
Hongchang Fu (H)
Kristiana Grigoriadis (K)
Claudia Lee (C)
Foteini Athanasopoulou (F)
Crispin Hiley (C)
Lily Robinson (L)
Tracey Horey (T)
Peter Russell (P)
Dionysis Papadatos-Pastos (D)
Sara Lock (S)
Kayleigh Gilbert (K)
Kayalvizhi Selvaraju (K)
Paul Ashford (P)
Oriol Pich (O)
Thomas B K Watkins (TBK)
Sophia Ward (S)
Emilia Lim (E)
Alexander M Frankell (AM)
Christopher Abbosh (C)
Robert E Hynds (RE)
Mariana Werner Sunderland (MW)
Karl Peggs (K)
Teresa Marafioti (T)
John A Hartley (JA)
Helen Lowe (H)
Leah Ensell (L)
Victoria Spanswick (V)
Angeliki Karamani (A)
David Moore (D)
Stephan Beck (S)
Olga Chervova (O)
Miljana Tanic (M)
Ariana Huebner (A)
Michelle Dietzen (M)
James R M Black (JRM)
Carlos Martinez Ruiz (CM)
Robert Bentham (R)
Cristina Naceur-Lombardelli (C)
Haoran Zhai (H)
Nnennaya Kanu (N)
Francisco Gimeno-Valiente (F)
Supreet Kaur Bola (SK)
Ignacio Garcia Matos (IG)
Mansi Shah (M)
Felipe Galvez Cancino (FG)
Despoina Karagianni (D)
Maryam Razaq (M)
Mita Akther (M)
Diana Johnson (D)
Joanne Laycock (J)
Elena Hoxha (E)
Benny Chain (B)
David R Pearce (DR)
Kezhong Chen (K)
Javier Herrero (J)
Fleur Monk (F)
Simone Zaccaria (S)
Neil Magno (N)
Paulina Prymas (P)
Antonia Toncheva (A)
Monica Sivakumar (M)
Olivia Lucas (O)
Mark S Hill (MS)
Othman Al-Sawaf (O)
Seng Kuong Ung (SK)
Sam Gamble (S)
Sophia Wong (S)
David Lawrence (D)
Martin Hayward (M)
Nikolaos Panagiotopoulos (N)
Robert George (R)
Davide Patrini (D)
Mary Falzon (M)
Elaine Borg (E)
Reena Khiroya (R)
Asia Ahmed (A)
Magali Taylor (M)
Junaid Choudhary (J)
Sam M Janes (SM)
Martin Forster (M)
Tanya Ahmad (T)
Siow Ming Lee (SM)
Neal Navani (N)
Marco Scarci (M)
Pat Gorman (P)
Elisa Bertoja (E)
Robert C M Stephens (RCM)
Emilie Martinoni Hoogenboom (EM)
James W Holding (JW)
Steve Bandula (S)
Ricky Thakrar (R)
James Wilson (J)
Mansi Shah (M)
None Marcos
Vasquez Duran (V)
Maria Litovchenko (M)
Sharon Vanloo (S)
Piotr Pawlik (P)
Kerstin Thol (K)
Babu Naidu (B)
Gerald Langman (G)
Hollie Bancroft (H)
Salma Kadiri (S)
Gary Middleton (G)
Madava Djearaman (M)
Aya Osman (A)
Helen Shackleford (H)
Akshay Patel (A)
Christian Ottensmeier (C)
Serena Chee (S)
Aiman Alzetani (A)
Judith Cave (J)
Lydia Scarlett (L)
Jennifer Richards (J)
Papawadee Ingram (P)
Emily Shaw (E)
John Le Quesne (J)
Alan Dawson (A)
Domenic Marrone (D)
Sean Dulloo (S)
Claire Wilson (C)
Yvonne Summers (Y)
Raffaele Califano (R)
Rajesh Shah (R)
Piotr Krysiak (P)
Kendadai Rammohan (K)
Eustace Fontaine (E)
Richard Booton (R)
Matthew Evison (M)
Stuart Moss (S)
Juliette Novasio (J)
Leena Joseph (L)
Paul Bishop (P)
Helen Doran (H)
Felice Granato (F)
Vijay Joshi (V)
Elaine Smith (E)
Angeles Montero (A)
Phil Crosbie (P)

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2022. The Author(s).

Références

Allen, E. M. V. et al. Genomic correlates of response to CTLA-4 blockade in metastatic melanoma. Science 350, 207–211 (2015).
pubmed: 26359337 pmcid: 5054517 doi: 10.1126/science.aad0095
Rizvi, N. A. et al. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer. Science 348, 124–128 (2015).
pubmed: 25765070 pmcid: 4993154 doi: 10.1126/science.aaa1348
McGranahan, N. et al. Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade. Science 351, 1463–1469 (2016).
pubmed: 26940869 pmcid: 4984254 doi: 10.1126/science.aaf1490
Hellmann, M. D. et al. Nivolumab plus ipilimumab in lung cancer with a high tumor mutational burden. N. Engl. J. Med. https://doi.org/10.1056/nejmoa1801946 (2018).
Tumeh, P. C. et al. PD-1 blockade induces responses by inhibiting adaptive immune resistance. Nature 515, 568–571 (2014).
pubmed: 25428505 pmcid: 4246418 doi: 10.1038/nature13954
Sade-Feldman, M. et al. Defining T cell states associated with response to checkpoint immunotherapy in melanoma. Cell 175, 998–1013.e20 (2018).
pubmed: 30388456 pmcid: 6641984 doi: 10.1016/j.cell.2018.10.038
Shim, J. H. et al. HLA-corrected tumor mutation burden and homologous recombination deficiency for the prediction of response to PD-(L)1 blockade in advanced non-small-cell lung cancer patients. Ann. Oncol. 31, 902–911 (2020).
Ansell, S. M. et al. PD-1 blockade with nivolumab in relapsed or refractory Hodgkin’s lymphoma. N. Engl. J. Med. https://doi.org/10.1056/nejmoa1411087 (2014).
Hellmann, M. D. et al. Genomic features of response to combination immunotherapy in patients with advanced non-small-cell lung cancer. Cancer Cell 33, e4 (2018).
doi: 10.1016/j.ccell.2018.03.018
Gentles, A. J. et al. The prognostic landscape of genes and infiltrating immune cells across human cancers. Nat. Med. 21, 938–945 (2015).
pubmed: 26193342 pmcid: 4852857 doi: 10.1038/nm.3909
Wu, Y. et al. An innate-like Vδ1
pubmed: 31597756 pmcid: 6877350 doi: 10.1126/scitranslmed.aax9364
Mikulak, J. et al. NKp46-expressing human gut-resident intraepithelial Vδ1 T cell subpopulation exhibits high antitumor activity against colorectal cancer. JCI Insight 4, 8900–8920 (2019).
doi: 10.1172/jci.insight.125884
Foord, E., Arruda, L. C. M., Gaballa, A., Klynning, C. & Uhlin, M. Characterization of ascites- and tumor-infiltrating γδ T cells reveals distinct repertoires and a beneficial role in ovarian cancer. Sci. Transl. Med. 13, eabb0192 (2021).
pubmed: 33472952 doi: 10.1126/scitranslmed.abb0192
Zakeri, N. et al. Characterisation and induction of tissue-resident gamma delta T cells to target hepatocellular carcinoma. Nat. Commun. 13, 1372 (2022).
pubmed: 35296658 pmcid: 8927126 doi: 10.1038/s41467-022-29012-1
Hayday, A. C. & Vantourout, P. The innate biologies of adaptive antigen rReceptors. Annu. Rev. Immunol. 38, 1–24 (2020).
doi: 10.1146/annurev-immunol-102819-023144
Girardi, M. et al. Regulation of cutaneous malignancy by gammadelta T cells. Science 294, 605–609 (2001).
pubmed: 11567106 doi: 10.1126/science.1063916
Girardi, M. et al. The distinct contributions of murine T cell receptor (TCR)γδ
pubmed: 12953094 pmcid: 2194182 doi: 10.1084/jem.20021282
Wu, P. et al. γδT17 cells promote the accumulation and expansion of myeloid-derived suppressor cells in human colorectal cancer. Immunity 40, 785–800 (2014).
pubmed: 24816404 pmcid: 4716654 doi: 10.1016/j.immuni.2014.03.013
Daley, D. et al. γδ T cells support pancreatic oncogenesis by restraining αβ T cell activation. Cell 166, 1485–1499.e15 (2016).
pubmed: 27569912 pmcid: 5017923 doi: 10.1016/j.cell.2016.07.046
Carding, S. R. & Egan, P. J. Gammadelta T cells: functional plasticity and heterogeneity. Nat. Rev. Immunol. 2, 336–345 (2002).
pubmed: 12033739 doi: 10.1038/nri797
Craven, K. E., Gökmen-Polar, Y. & Badve, S. S. CIBERSORT analysis of TCGA and METABRIC identifies subgroups with better outcomes in triple negative breast cancer. Sci. Rep. 11, 4691 (2021).
pubmed: 33633150 pmcid: 7907367 doi: 10.1038/s41598-021-83913-7
Jamal-Hanjani, M. et al. Tracking the evolution of non-small-cell lung cancer. N. Engl. J. Med. 376, 2109–2121 (2017).
pubmed: 28445112 doi: 10.1056/NEJMoa1616288
Zappa, C. & Mousa, S. A. Non-small cell lung cancer: current treatment and future advances. Transl. Lung Cancer Res. 5, 288–300 (2016).
pubmed: 27413711 pmcid: 4931124 doi: 10.21037/tlcr.2016.06.07
Rosenthal, R. et al. Neoantigen-directed immune escape in lung cancer evolution. Nature 567, 479–485 (2019).
pubmed: 30894752 pmcid: 6954100 doi: 10.1038/s41586-019-1032-7
Alexandrov, L. B. et al. Signatures of mutational processes in human cancer. Nature 500, 415–421 (2013).
pubmed: 23945592 pmcid: 3776390 doi: 10.1038/nature12477
Shankaran, V. et al. IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature 410, 1107–1111 (2001).
pubmed: 11323675 doi: 10.1038/35074122
Gao, J. et al. Loss of IFN-γ pathway genes in tumor cells as a mechanism of resistance to anti-CTLA-4 therapy. Cell 167, 397–404.e9 (2016).
pubmed: 27667683 pmcid: 5088716 doi: 10.1016/j.cell.2016.08.069
Rooney, M. S., Shukla, S. A., Wu, C. J., Getz, G. & Hacohen, N. Molecular and genetic properties of tumors associated with local immune cytolytic activity. Cell 160, 48–61 (2015).
pubmed: 25594174 pmcid: 4856474 doi: 10.1016/j.cell.2014.12.033
Pang, D. J., Neves, J. F., Sumaria, N. & Pennington, D. J. Understanding the complexity of γδ T cell subsets in mouse and human. Immunology 136, 283–290 (2012).
pubmed: 22385416 pmcid: 3385028 doi: 10.1111/j.1365-2567.2012.03582.x
Carithers, L. J. et al. A novel approach to high-quality postmortem tssue procurement: the GTEx project. Biopreserv. Biobank 13, 311–319 (2015).
pubmed: 26484571 pmcid: 4675181 doi: 10.1089/bio.2015.0032
Farber, D. L., Yudanin, N. A. & Restifo, N. P. Human memory T cells: generation, compartmentalization and homeostasis. Nat. Rev. Immunol. 14, 24–35 (2013).
pubmed: 24336101 pmcid: 4032067 doi: 10.1038/nri3567
Purwar, R. et al. Resident memory T cells (T
pubmed: 21298112 pmcid: 3027667 doi: 10.1371/journal.pone.0016245
Snyder, M. E. et al. Generation and persistence of human tissue-resident memory T cells in lung transplantation. Sci. Immunol. 4, eaav5581 (2019).
pubmed: 30850393 pmcid: 6435356 doi: 10.1126/sciimmunol.aav5581
Webb, J. R., Milne, K. & Nelson, B. H. PD-1 and CD103 are widely coexpressed on prognostically favorable intraepithelial CD8 T cells in human ovarian cancer. Cancer Immunol. 3, 926–935 (2015).
doi: 10.1158/2326-6066.CIR-14-0239
Savas, P. et al. Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis. Nat. Med. 24, 986–993 (2018).
pubmed: 29942092 doi: 10.1038/s41591-018-0078-7
Djenidi, F. et al. CD8
pubmed: 25725111 doi: 10.4049/jimmunol.1402711
Silva-Santos, B., Mensurado, S. & Coffelt, S. B. γδ T cells: pleiotropic immune effectors with therapeutic potential in cancer. Nat. Rev. Cancer https://doi.org/10.1038/s41568-019-0153-5 (2019).
Davey, M. S. et al. Clonal selection in the human Vδ1 T cell repertoire indicates γδ TCR-dependent adaptive immune surveillance. Nat. Commun. 8, 14760 (2017).
pubmed: 28248310 pmcid: 5337994 doi: 10.1038/ncomms14760
Uhlen, M. et al. A genome-wide transcriptomic analysis of protein-coding genes in human blood cells. Science 366, eaax9198 (2019).
Ness-Schwickerath, K. J., Jin, C. & Morita, C. T. Cytokine requirements for the differentiation and expansion of IL-17A- and IL-22-producing human Vγ2Vδ2 T cells. J. Immunol. 184, 7268–7280 (2010).
pubmed: 20483730 doi: 10.4049/jimmunol.1000600
Tan, L. et al. A fetal wave of human type 3 effector γδ cells with restricted TCR diversity persists into adulthood. Sci. Immunol. 6, eabf0125 (2021).
pubmed: 33893173 doi: 10.1126/sciimmunol.abf0125
Caccamo, N. et al. Differentiation, phenotype, and function of interleukin-17–producing human Vγ9Vδ2 T cells. Blood 118, 129–138 (2011).
pubmed: 21505189 doi: 10.1182/blood-2011-01-331298
Groh, V., Steinle, A., Bauer, S. & Spies, T. Recognition of stress-induced MHC molecules by intestinal epithelial γδ T cells. Science 279, 1737–1740 (1998).
pubmed: 9497295 doi: 10.1126/science.279.5357.1737
Sherwood, A. M. et al. Deep sequencing of the human TCRγ and TCRβ repertoires suggests that TCRβ rearranges after αβ and γδ T cell commitment. Sci. Transl. Med. 3, 90ra61 (2011).
pubmed: 21734177 pmcid: 4179204 doi: 10.1126/scitranslmed.3002536
Szabo, P. A., Miron, M. & Farber, D. L. Location, location, location: tissue resident memory T cells in mice and humans. Sci. Immunol. 4, eaas9673 (2019).
pubmed: 30952804 pmcid: 6778482 doi: 10.1126/sciimmunol.aas9673
Bergsbaken, T. & Bevan, M. J. Proinflammatory microenvironments within the intestine regulate differentiation of tissue-resident CD8 T cells responding to infection. Nat. Immunol. 16, 406–414 (2015).
pubmed: 25706747 pmcid: 4368475 doi: 10.1038/ni.3108
Christo, S. N. et al. Discrete tissue microenvironments instruct diversity in resident memory T cell function and plasticity. Nat. Immunol. https://doi.org/10.1038/s41590-021-01004-1 (2021).
Mackay, L. K. et al. The developmental pathway for CD103
pubmed: 24162776 doi: 10.1038/ni.2744
Kumar, B. V. et al. Human tissue-resident memory T cells are defined by core transcriptional and functional signatures in lymphoid and mucosal sites. Cell Rep. 20, 2921–2934 (2017).
pubmed: 28930685 pmcid: 5646692 doi: 10.1016/j.celrep.2017.08.078
Im, S. J. et al. Defining CD8
pubmed: 27501248 pmcid: 5297183 doi: 10.1038/nature19330
Alfei, F. et al. TOX reinforces the phenotype and longevity of exhausted T cells in chronic viral infection. Nature 571, 265–269 (2019).
pubmed: 31207605 doi: 10.1038/s41586-019-1326-9
Eberhardt, C. S. et al. Functional HPV-specific PD-1
pubmed: 34471285 doi: 10.1038/s41586-021-03862-z
Siddiqui, I. et al. Intratumoral Tcf1
pubmed: 30635237 doi: 10.1016/j.immuni.2018.12.021
McCarthy, N. E. & Eberl, M. Human γδ T cell control of mucosal immunity and inflammation. Front. Immunol. 9, 985 (2018).
pubmed: 29867962 pmcid: 5949325 doi: 10.3389/fimmu.2018.00985
Villartay, J.-P., de Hockett, R. D., Coran, D., Korsmeyer, S. J. & Cohen, D. I. Deletion of the human T cell receptor δ-gene by a site-specific recombination. Nature 335, 170–174 (1988).
pubmed: 2842691 doi: 10.1038/335170a0
Yang, S. Y. C. et al. Pan-cancer analysis of longitudinal metastatic tumors reveals genomic alterations and immune landscape dynamics associated with pembrolizumab sensitivity. Nat. Commun. 12, 5137 (2021).
doi: 10.1038/s41467-021-25432-7
Schenkel, J. M. & Masopust, D. Tissue-resident memory T cells. Immunity 41, 886–897 (2014).
pubmed: 25526304 pmcid: 4276131 doi: 10.1016/j.immuni.2014.12.007
Strid, J. et al. Acute upregulation of an NKG2D ligand promotes rapid reorganization of a local immune compartment with pleiotropic effects on carcinogenesis. Nat. Immunol. 9, 146–154 (2008).
pubmed: 18176566 doi: 10.1038/ni1556
Gao, Y. et al. γδ T cells provide an early source of interferon γ in tumor immunity. J. Exp. Med. 198, 433–442 (2003).
pubmed: 12900519 pmcid: 2194096 doi: 10.1084/jem.20030584
Wu, Y. et al. Human gamma delta T cells: a lymphoid lineage cell capable of professional phagocytosis. J. Immunol. 183, 5622–5629 (2009).
pubmed: 19843947 doi: 10.4049/jimmunol.0901772
Junqueira, C. et al. γδ T cells suppress Plasmodium falciparum blood-stage infection by direct killing and phagocytosis. Nat. Immunol. https://doi.org/10.1038/s41590-020-00847-4 (2021).
Brandes, M., Willimann, K. & Moser, B. Professional antigen-presentation function by human γδ T cells. Science 309, 264–268 (2005).
pubmed: 15933162 doi: 10.1126/science.1110267
Hayday, A. C. γδ T cell update: adaptate orchestrators of immune surveillance. J. Immunol. 203, 311–320 (2019).
pubmed: 31285310 doi: 10.4049/jimmunol.1800934
Kakimi, K. et al. Adoptive transfer of zoledronate-expanded autologous Vγ9Vδ2 T cells in patients with treatment-refractory non-small-cell lung cancer: a multicenter, open-label, single-arm, phase 2 study. J. Immunother. Cancer 8, e001185 (2020).
pubmed: 32948652 pmcid: 7511646 doi: 10.1136/jitc-2020-001185
Almeida, A. R. et al. Delta one T cells for immunotherapy of chronic lymphocytic leukemia: clinical-grade expansion/ differentiation and preclinical proof-of-concept. Clin. Cancer Res. 22, 5795–5804 (2016).
Coffelt, S. B. et al. IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis. Nature 522, 345–348 (2015).
pubmed: 25822788 pmcid: 4475637 doi: 10.1038/nature14282
Jin, C. et al. Commensal microbiota promote lung cancer development via γδ T cells. Cell 176, 998–1013 (2019).
pubmed: 30712876 pmcid: 6691977 doi: 10.1016/j.cell.2018.12.040
Vries, N. L. de et al. γδ T cells are effectors of immune checkpoint blockade in mismatch repair-deficient colon cancers with antigen presentation defects. Preprint at bioRxiv https://doi.org/10.1101/2021.10.14.464229 (2021).
Payne, K. K. et al. BTN3A1 governs antitumor responses by coordinating αβ and γδ T cells. Science 369, 942–949 (2020).
pubmed: 32820120 pmcid: 7646930 doi: 10.1126/science.aay2767
Godder, K. T. et al. Long term disease-free survival in acute leukemia patients recovering with increased γδ T cells after partially mismatched related donor bone marrow transplantation. Bone Marrow Transpl. 39, 751–757 (2007).
doi: 10.1038/sj.bmt.1705650
Li, B. & Dewey, C. N. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinf. 12, 323 (2011).
doi: 10.1186/1471-2105-12-323
Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15–21 (2013).
pubmed: 23104886 doi: 10.1093/bioinformatics/bts635
DeLuca, D. S. et al. RNA-SeQC: RNA-seq metrics for quality control and process optimization. Bioinformatics 28, 1530–1532 (2012).
pubmed: 22539670 pmcid: 3356847 doi: 10.1093/bioinformatics/bts196
Martin, M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet J 17, 10–12 (2011).
doi: 10.14806/ej.17.1.200
McKenna, A. et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 20, 1297–1303 (2010).
pubmed: 20644199 pmcid: 2928508 doi: 10.1101/gr.107524.110
Hartley, S. W. & Mullikin, J. C. QoRTs: a comprehensive toolset for quality control and data processing of RNA-Seq experiments. BMC Bioinf. 16, 224 (2015).
doi: 10.1186/s12859-015-0670-5
Pedersen, B. S. et al. Somalier: rapid relatedness estimation for cancer and germline studies using efficient genome sketches. Genome Med. 12, 62 (2020).
pubmed: 32664994 pmcid: 7362544 doi: 10.1186/s13073-020-00761-2
Ewels, P., Magnusson, M., Lundin, S. & Käller, M. MultiQC: summarize analysis results for multiple tools and samples in a single report. Bioinformatics 32, 3047–3048 (2016).
pubmed: 27312411 pmcid: 5039924 doi: 10.1093/bioinformatics/btw354
Colaprico, A. et al. TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data. Nucleic Acids Res. 44, e71 (2016).
pubmed: 26704973 doi: 10.1093/nar/gkv1507
Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).
pubmed: 25516281 pmcid: 4302049 doi: 10.1186/s13059-014-0550-8

Auteurs

Yin Wu (Y)

Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. yin.wu@kcl.ac.uk.
Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK. yin.wu@kcl.ac.uk.
Peter Gorer Department of Immunobiology, School of Immunology & Microbial Sciences, King's College London, London, UK. yin.wu@kcl.ac.uk.
Immunosurveillance Laboratory, The Francis Crick Institute, London, UK. yin.wu@kcl.ac.uk.

Dhruva Biswas (D)

Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
Bill Lyons Informatics Centre, University College London Cancer Institute, London, UK.

Ieva Usaite (I)

Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.

Mihaela Angelova (M)

Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.

Stefan Boeing (S)

Bioinformatics & Biostatistics and Software Development & Machine Learning Team, The Francis Crick Institute, London, UK.

Takahiro Karasaki (T)

Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.

Selvaraju Veeriah (S)

Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.

Justyna Czyzewska-Khan (J)

Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.

Cienne Morton (C)

Peter Gorer Department of Immunobiology, School of Immunology & Microbial Sciences, King's College London, London, UK.

Magdalene Joseph (M)

Peter Gorer Department of Immunobiology, School of Immunology & Microbial Sciences, King's College London, London, UK.
Immunosurveillance Laboratory, The Francis Crick Institute, London, UK.

Sonya Hessey (S)

Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Cancer Metastasis Lab, University College London Cancer Institute, London, UK.

James Reading (J)

Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK.

Andrew Georgiou (A)

Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK.

Maise Al-Bakir (M)

Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.

Nicholas McGranahan (N)

Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Cancer Genome Evolution Research Group, University College London Cancer Institute, London, UK.

Mariam Jamal-Hanjani (M)

Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Cancer Metastasis Lab, University College London Cancer Institute, London, UK.

Allan Hackshaw (A)

Cancer Research UK & University College London Cancer Trials Centre, University College London, London, UK.

Sergio A Quezada (SA)

Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK.

Adrian C Hayday (AC)

Peter Gorer Department of Immunobiology, School of Immunology & Microbial Sciences, King's College London, London, UK. adrian.hayday@kcl.ac.uk.
Immunosurveillance Laboratory, The Francis Crick Institute, London, UK. adrian.hayday@kcl.ac.uk.

Charles Swanton (C)

Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. charles.swanton@crick.ac.uk.
Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK. charles.swanton@crick.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH